Raphael Pharmaceutical Inc. (RAPH) — 10-Q Filings

10-Q Filings (6)

• Raphael Pharma's Cash Dries Up Amid Mounting Losses — Nov 13, 2025 Risk: high
  Raphael Pharmaceutical Inc. (RAPH) reported a net loss of $1.006 million for the nine months ended September 30, 2025, a decrease from the $1.124 million net lo
• Raphael Pharma's Deficit Widens Amidst Continued R&D Stage — Aug 13, 2025 Risk: high
  Raphael Pharmaceutical Inc. (RAPH) reported an accumulated deficit of $9,640 thousand as of June 30, 2025, an increase from $8,889 thousand at December 31, 2024
• Raphael Pharmaceutical Files Q1 2025 10-Q — May 15, 2025 Risk: low
  Raphael Pharmaceutical Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Easy Energy Inc., is incorporated in
• Raphael Pharmaceutical Files Q3 2024 10-Q — Nov 14, 2024 Risk: low
  Raphael Pharmaceutical Inc. filed its 10-Q for the quarterly period ended September 30, 2024. The company, formerly known as Easy Energy Inc. until October 17,
• Raphael Pharmaceutical Files Q2 2024 10-Q — Aug 12, 2024 Risk: low
  Raphael Pharmaceutical Inc. filed its 10-Q for the quarterly period ended June 30, 2024. The company, formerly known as Easy Energy Inc., is incorporated in Nev
• Raphael Pharmaceutical Inc. Files 10-Q for Period Ended March 31, 2024 — May 15, 2024 Risk: low
  Raphael Pharmaceutical Inc. (RAPH) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Raphael Pharmaceutical Inc. filed a 10-Q report for the quarter

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX